ProMed BioSciences

Limassol, Cyprus

Promed Bioscience is a provider of manufacture and supply of highly purified research and medical grade collagen from animal tissue.

$1.4M raised

Nov 2025

Venture - Series Unknown

Biotechnology Manufacturing Pharmaceutical

Top Investors

Kinisis VenturesAsbis

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ProMed BioSciences

How much funding has ProMed BioSciences raised?

ProMed BioSciences has raised $1.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.

Who are ProMed BioSciences's investors?

ProMed BioSciences's investors include Kinisis Ventures, Asbis.

Where is ProMed BioSciences headquartered?

ProMed BioSciences is headquartered in Limassol, Cyprus.

What does ProMed BioSciences do?

Promed Bioscience is a provider of manufacture and supply of highly purified research and medical grade collagen from animal tissue.

What stage is ProMed BioSciences at?

ProMed BioSciences is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 25, 2025.

MLA

"ProMed BioSciences — Funding & Investors." VCBacked, November 25, 2025, https://www.vcbacked.co/company/promed-biosciences. Accessed June 13, 2026.

APA

VCBacked. (2025). ProMed BioSciences — Funding & Investors. Retrieved June 13, 2026, from https://www.vcbacked.co/company/promed-biosciences

Wikipedia (cite web)

{{cite web |title=ProMed BioSciences — Funding & Investors |url=https://www.vcbacked.co/company/promed-biosciences |website=VCBacked |access-date=June 13, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 25, 2025.